TRACON Pharmaceuticals, Inc. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8912a3d9-577b-42b6-8a23-dfc402c6ab24/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-3.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-026205 |
| FY 2022 | $-29.1M | 2022-01-01 – 2022-12-31 | evidence 0001564590-23-003313 |
| FY 2021 | $-28.7M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010475 |
| FY 2020 | $-16.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008957 |
| FY 2019 | $-22.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007520 |
| FY 2018 | $-35.0M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005597 |
| FY 2017 | $-19.1M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-003925 |
| FY 2016 | $-27.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-002953 |
| FY 2015 | $-24.4M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-003288 |
| FY 2014 | $-6.8M | 2014-01-01 – 2014-12-31 | evidence 0001558370-16-003288 |
| FY 2013 | $-7.7M | 2013-01-01 – 2013-12-31 | evidence 0001558370-16-003288 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TRACON Pharmaceuticals, Inc. — all facts · Revenue · Operating Income